Life AI Net
ホーム
アーカイブ
計算ツール
ディレクトリ
ニュースレター
ログイン
日本語
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
ホーム
アーカイブ
計算ツール
ディレクトリ
ニュースレター
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
ログイン
ホーム
アーカイブ
計算ツール
ディレクトリ
More
ライブ
10x Genomics News
Vanguard holds 6.17M shares of 10X Genomics (NASDAQ: TXG), 5.24% stake - Stock Titan
10x Genomics Blog
10x Genomics investors can watch management at a May 13 BofA chat - Stock Titan
10x Genomics News
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - PR Newswire
10x Genomics Blog
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - Yahoo Finance UK
FierceBiotech
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
Endpoints News
AbbVie faces questions about Skyrizi competition from J&J
Endpoints News
FDA, AstraZeneca prep for oncology adcomm
Agilent
PCR Plate Sealer Market Leading Players Analysis - Agilent - openPR.com
10x Genomics News
Why 10x Genomics Stock Is Sinking Today - TipRanks
Lonza News
Lonza Capsugel donates $50,000 to Project Hope Foundation - Index-Journal
FierceBiotech
AstraZeneca scraps FLAP inhibitor after flunking phase 2 asthma trial
10x Genomics News
Vanguard holds 6.17M shares of 10X Genomics (NASDAQ: TXG), 5.24% stake - Stock Titan
10x Genomics Blog
10x Genomics investors can watch management at a May 13 BofA chat - Stock Titan
10x Genomics News
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - PR Newswire
10x Genomics Blog
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - Yahoo Finance UK
FierceBiotech
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
Endpoints News
AbbVie faces questions about Skyrizi competition from J&J
Endpoints News
FDA, AstraZeneca prep for oncology adcomm
Agilent
PCR Plate Sealer Market Leading Players Analysis - Agilent - openPR.com
10x Genomics News
Why 10x Genomics Stock Is Sinking Today - TipRanks
Lonza News
Lonza Capsugel donates $50,000 to Project Hope Foundation - Index-Journal
FierceBiotech
AstraZeneca scraps FLAP inhibitor after flunking phase 2 asthma trial
アーカイブ
BioWorld
2026年4月29日
Regulatory actions for April 29, 2026
Regulatory actions for April 29, 2026
原文
本文は利用できません。元の情報源をご確認ください。